2015 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 12
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Connecticut | 335 | 28.0 | 3.7 | (20.7 – 35.3) | 368 | 27.7 | 3.5 | (20.8 – 34.6) |
| Florida | 200 | 31.4 | 4.6 | (22.4 – 40.4) | 223 | 29.2 | 4.3 | (20.8 – 37.6) |
| Georgia | 165 | 35.2 | 5.6 | (24.2 – 46.2) | 168 | 38.1 | 5.8 | (26.7 – 49.5) |
| Hawaii | 161 | 38.7 | 6.3 | (26.4 – 51.0) | 191 | 31.4 | 5.5 | (20.6 – 42.2) |
| Indiana | 189 | 31.7 | 6.0 | (19.9 – 43.5) | 204 | 34.9 | 6.0 | (23.1 – 46.7) |
| Iowa | 179 | 25.8 | 4.3 | (17.4 – 34.2) | 191 | 24.6 | 4.1 | (16.6 – 32.6) |
| Kansas | 568 | 29.1 | 2.5 | (24.2 – 34.0) | 588 | 29.5 | 2.5 | (24.6 – 34.4) |
| Maine | 251 | 26.8 | 4.0 | (19.0 – 34.6) | 263 | 25.8 | 3.8 | (18.4 – 33.2) |
| Massachusetts | 240 | 38.1 | 5.3 | (27.7 – 48.5) | 267 | 36.1 | 4.9 | (26.5 – 45.7) |
| Michigan | 394 | 33.9 | 3.1 | (27.8 – 40.0) | 425 | 31.8 | 2.9 | (26.1 – 37.5) |
| Minnesota | 584 | 24.9 | 2.5 | (20.0 – 29.8) | 608 | 24.4 | 2.3 | (19.9 – 28.9) |
| Mississippi | 143 | 44.2 | 7.1 | (30.3 – 58.1) | 145 | 42.2 | 7.2 | (28.1 – 56.3) |
| Missouri | 182 | 40.7 | 5.8 | (29.3 – 52.1) | 190 | 39.9 | 5.7 | (28.7 – 51.1) |
| Montana | 138 | 26.4 | 6.4 | (13.9 – 38.9) | 142 | 26.4 | 6.2 | (14.2 – 38.6) |
| Nebraska | 450 | 21.6 | 3.0 | (15.7 – 27.5) | 482 | 19.7 | 2.7 | (14.4 – 25.0) |
| Nevada | 104 | 29.1 | 6.8 | (15.8 – 42.4) | 109 | 32.5 | 7.3 | (18.2 – 46.8) |
| New Hampshire | 205 | 25.7 | 4.6 | (16.7 – 34.7) | 209 | 25.8 | 4.5 | (17.0 – 34.6) |
| New Jersey | 404 | 22.5 | 3.1 | (16.4 – 28.6) | 431 | 22.5 | 3.0 | (16.6 – 28.4) |
| New Mexico | 251 | 34.3 | 4.8 | (24.9 – 43.7) | 267 | 36.8 | 4.7 | (27.6 – 46.0) |
| New York | 204 | 37.2 | 5.5 | (26.4 – 48.0) | 227 | 37.0 | 5.3 | (26.6 – 47.4) |
| Ohio | 371 | 33.5 | 4.9 | (23.9 – 43.1) | 410 | 30.7 | 4.4 | (22.1 – 39.3) |
| Oregon | 185 | 39.3 | 5.2 | (29.1 – 49.5) | 210 | 40.1 | 5.0 | (30.3 – 49.9) |
| Pennsylvania | 194 | 27.8 | 5.0 | (18.0 – 37.6) | 213 | 31.5 | 4.6 | (22.5 – 40.5) |
| Rhode Island | 199 | 20.5 | 4.0 | (12.7 – 28.3) | 213 | 20.8 | 3.9 | (13.2 – 28.4) |
| Texas | 338 | 31.6 | 4.8 | (22.2 – 41.0) | 395 | 29.2 | 4.4 | (20.6 – 37.8) |
| Utah | 358 | 22.0 | 2.9 | (16.3 – 27.7) | 387 | 21.8 | 2.7 | (16.5 – 27.1) |
| Vermont | 242 | 19.8 | 3.4 | (13.1 – 26.5) | 247 | 20.4 | 3.4 | (13.7 – 27.1) |
| Wisconsin | 277 | 28.1 | 4.2 | (19.9 – 36.3) | 286 | 25.9 | 4.0 | (18.1 – 33.7) |
| Puerto Rico | 274 | 48.5 | 3.8 | (41.1 – 55.9) | 310 | 49.6 | 3.6 | (42.5 – 56.7) |
| 29 states / area | 7,785 | 32.6 | 1.3 | (30.1 – 35.1) | 8,369 | 32.0 | 1.2 | (29.6 – 34.4) |
| Median | 29.1 | 29.5 | ||||||
| Range | 19.8-48.5 | 19.7-49.6 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
Page last reviewed: June 11, 2018